C12N2710/24041 - CPC Classification Index

ClassID:

109998 ⎘

C12N2710/24041 - CPC Classification

Classification description:

dsDNA viruses; Details; Poxviridae Use of virus, viral particle or viral elements as a vector

Sub-classes:

C12N2710/24042 » virus or viral particle as vehicle, e.g. encapsulating small organic molecule 4
C12N2710/24043 » viral genome or elements thereof as genetic vector 124
C12N2710/24044 » Chimeric viral vector comprising heterologous viral elements for production of another viral vector 2
C12N2710/24045 » Special targeting system for viral vectors 0

Recent Application in this class:

20240254161

2024-08-01

Neoantigens Expressed In Ovarian Cancer And Their Uses

20220088170

2022-03-24

Methods and compositions for inducing protective immunity against filovirus infection

20220072122

2022-03-10

Method for generating recombinant poxviruses

20210261609

2021-08-26

Neoantigens expressed in ovarian cancer and their uses

20200164061

2020-05-28

Poxviral vaccines

20200038500

2020-02-06

Methods and compositions for inducing protective immunity against filovirus infection

20180148739

2018-05-31

Recombinant Orf virus vector

20180125968

2018-05-10

Poxviral vaccines

20180064760

2018-03-08

Myxoma-treated graft material for cancer treatment

#10

20170290904

2017-10-12

Methods and compositions for inducing protective immunity against filovirus infection

#11

20170266270

2017-09-21

Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor

#12

20160000904

2016-01-07

IMPROVED POXVIRAL VACCINES

#13

20150361141

2015-12-17

Crimean-congo haemorrhagic fever virus antigenic composition

#14

20150265688

2015-09-24

Stabilizing Formulations for Recombinant Viruses

#15

20140328804

2014-11-06

Method for treating or preventing graft versus host disease

#16

20090169581

2009-07-02

STABILIZING FORMULATIONS FOR RECOMBINANT VIRUSES